Trend in number of clinical studies, involved adipose tissue-derived cells, listed as trials in international registries

This graph demonstrates the trend in sponsorship of cell therapy clinical trials, involved adipose tissue-derived cells, listed in international databases.

Methodology described here:

http://celltrials.info/2015/01/22/2014-report/

Legend:

X axis: years, since 2011

Y axis: Number of "trials" newly listed in international registeries. It is not cumulative number - only listings, appeared between January 1 of particular year and January 1 of the next year.

Definitions:

"Industry" is a generic term, used to describe all "commercial" studies, listed in databases as (1) sponsored by a company or (2) private clinic or (3) involved company as collaborator, which manufactured/ prepared therapeutic cellular product.

"Academia" is a generic term, used to describe all other types of sponsorship, different from "industry"/ commercial.

Adipose tissue-derived cells include (1) freshly isolated stromal vascular fraction, used therapeutically at point-of-care and (2) cultured and ex-vivo expanded stem cells.